← Eichor
Study identifier: NCT05486793 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study

Condition: PTSD  ·  Sponsor: Boston University

PhaseNA
Planned participants240
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersNo

About this study

The majority of women with perinatal posttraumatic stress disorder (PTSD) do not receive mental health treatment despite the documented associations between PTSD and adverse pregnancy outcomes; this is likely due to workforce shortages, lack of data on the effectiveness of existing evidence-based treatment for PTSD in usual care obstetrics settings, and patient-level barriers to engagement such as stigma. The proposed study is a randomized controlled trial, which will examine the effectiveness of a brief evidence-based treatment for PTSD (i.e., Written Exposure Therapy) during pregnancy and the non-inferiority of delivery of this treatment by community health workers vs. delivery by mental health clinicians.

This description comes directly from the study's public registry record.

Talk to the study team

Yael I Nillni, PhD  ·  781-413-6319  ·  yael.nillni@bmc.org

Hannah Brown, MS  ·  617-358-3324  ·  hannah.brown3@bmc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Boston Medical Center and remoteBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05486793